Community-acquired Chlamydia pneumoniae pneumonia

Falguera, M.; Nogues, A.; Ruiz-Gonzalez, A.
September 1996
Thorax;Sep1996, Vol. 51 Issue 9, p967
Academic Journal
No abstract available.


Related Articles

  • Atypical Pathogens and Challenges in Community-Acquired Pneumonia. Thibodeau, Kristopher P.; Viera, Anthony J. // American Family Physician;4/1/2004, Vol. 69 Issue 7, p1699 

    Provides information on atypical pathogens and community-acquired pneumonia. Respiratory infections caused by the mycoplasma pneumoniae pathogen; Information on chlamydia pneumoniae and legionella pneumophila pathogen; Efficacy of macrolide antibiotics; Discussion of the different challenges in...

  • Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in Children with Community-Acquired Lower Respiratory Tract Infections. Principi, Nicola; Esposito, Susanna; Blasi, Francesco; Allegra, Luigi // Clinical Infectious Diseases;5/1/2001, Vol. 32 Issue 9, p1281 

    Deals with a study which investigated the role of Mycoplasma pneumoniae and Chlamydia pneumoniae in community-acquired lower respiratory tract infections in children. Patients and methods; Demographics of the research participants; Incidence of pneumoniae infections.

  • Prevalence of atypical bacterial pathogens in hospitalised adult patients with community-acquired pneumonia in Central Greece. Neocleous, C.; Gerogianni, I.; Gourgoulianis, K.; Petinaki, E. // Indian Journal of Medical Microbiology;Apr2014, Vol. 32 Issue 2, p204 

    A letter to the editor is presented related to a research to determine the prevalence of atypical pathogens such as Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in the pathogenesis of Community-acquired pneumonia (CAP), a common disease causes morbidity and mortality.

  • Clinical Characteristics of Chlamydia pneumoniae Infection as the Sole Cause of Community-Acquired Pneumonia. File Jr., Thomas M.; Plouffe Jr., Joseph F.; Breiman, Robert F.; Skelton, Stephen K. // Clinical Infectious Diseases;8/1/1999, Vol. 29 Issue 2, p426 

    Evaluates the clinical characteristics of patients with community-acquired pneumonia (CAP) due to Chlamydia (C.) pneumoniae who required hospitalization. Basis of the diagnosis of C. pneumoniae; Characteristics of primary infection; Symptoms of patients with CAP.

  • Ciprofloxacin.  // Reactions Weekly;Nov2015, Vol. 1577 Issue 1, p80 

    The article presents a case study of 46-year-old man who developed Community-acquired Acinetobacter baumannii pneumonia following treatment with ciprofloxacin for Chlamydia pscittaci-induced pneumonia.

  • Importance of Atypical Pathogens of Community-Acquired Pneumonia. Plouffe, Joseph F. // Clinical Infectious Diseases;8/1/2000 Supplement 2, Vol. 31, pS35 

    Discusses data which suggest that in the Medicare population hospitalized with pneumonia, morbidity and mortality can be decreased if initial therapy includes coverage for atypical pathogens. Antimicrobial susceptibility pattern of Legionella species, Mycoplasma pneumoniae and Chlamydia...

  • Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as Causative Agents of Community-Acquired Pneumonia in Hospitalised Children and Adolescents. Baer, G.; Engelcke, G.; Abele-Horn, M.; Schaad, U. B.; Heininger, U. // European Journal of Clinical Microbiology & Infectious Diseases;Dec2003, Vol. 22 Issue 12, p742 

    The aim of the study presented here was to determine the prevalence of Chlamydia pneumoniae versus Mycoplasma pneumoniae infections in paediatric patients with community-acquired pneumonia. A total of 50 patients (mean age, 5.5 years; median, 3.9 years) with community-acquired pneumonia were...

  • Study: Atypical pneumonias not as rare in elderly as believed.  // Geriatrics;Dec1991, Vol. 46 Issue 12, p15 

    This article reports that community-acquired pneumonia caused by chlamydia pneumoniae appears to occur more often in older patients and to produce more serious illness than has been previously believed, according to Thomas M. File, MD, professor of medicine, Northeastern Ohio Universities...

  • Severe Community-Acquired Pneumonia with Acute Hypoxemic Respiratory Failure Due to Primary Infection with Chlamydia pneumoniae in a Previously Healthy Adult. Balis, Evangelos; Boufas, Anastasios; Iliopoulos, Ireneos; Legakis, Nicholaos J.; Zerva, Loukia // Clinical Infectious Diseases;6/15/2003, Vol. 36 Issue 12, pe155 

    Community-acquired pneumonia due to Chlamydia pneumoniae is associated with a benign clinical course. Severe, life-threatening pneumonia is rare and occurs only in immunocompromised hosts. We report a case of severe pneumonia complicated by acute hypoxemic respiratory failure due to primary...

  • The roles of the newer macrolide antibiotics in treating community-acquired pneumonia. Segreti, John // Modern Medicine;Oct94, Vol. 62 Issue 10, p30 

    Evaluates the efficacy of macrolide antibiotics clarithromycin and azithromycin in treating community-acquired pneumonia. Organisms that cause community-acquired pneumonia; Symptoms of community-acquired pneumonia; Pharmacokinetic differences; Efficacy comparisons.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics